The global Intravascular Ultrasound (IVUS) and Optical Coherence Tomography (OCT) market is poised for strong growth from 2025 to 2034, driven by the increasing prevalence of cardiovascular diseases (CVDs), advancements in AI-integrated imaging systems, and rising adoption in clinical decision-making and interventional cardiology.
These imaging technologies are critical in assessing vessel morphology, detecting plaque, guiding stent placement, and minimizing procedure-related complications.
North America held ~48% of the global market in 2024.
Asia Pacific is projected to grow at the fastest rate through 2034.
The IVUS segment dominated with ~58% market share in 2024.
The OCT segment is expected to grow at >8% CAGR during the forecast period.
By product, imaging catheters led the market in 2024.
Imaging consoles/systems are projected to be the fastest-growing segment moving forward.
About: A leading Dutch multinational in healthcare technology.
Products: IVUS systems (Eagle Eye Platinum catheter, Core Mobile system), and integrated imaging platforms.
Market Cap: Approx. $22 billion (as of 2025).
Strength: Strong innovation in intravascular imaging and global reach.
About: U.S.-based healthcare giant known for cardiovascular and diagnostic products.
Products: Optis™ Integrated OCT Imaging System, Dragonfly™ Imaging Catheters.
Market Cap: Around $170 billion (2025).
Strength: Extensive clinical adoption and product development for coronary imaging.
About: Major medical device manufacturer headquartered in the U.S.
Products: Polaris Multi-Modality Guidance System, OptiCross IVUS catheter.
Market Cap: Around $90 billion.
Strength: Focus on minimally invasive interventions and advanced image guidance.
About: A leading Japanese medical technology company.
Products: Lunawave IVUS System, Micro Guidewires.
Market Cap: Around $25 billion.
Strength: Strong in Asia-Pacific, extensive product pipeline in cardiology.
About: U.S.-based, part of the Italian Bracco Imaging group.
Products: HDi® HD IVUS system, Kodama® catheter.
Market Cap: Privately held (Bracco Group estimated value ~$2 billion).
Strength: Known for high-definition IVUS imaging solutions.
About: A U.S. company specializing in intravascular imaging, acquired by Nipro.
Products: TVC Imaging System, combining IVUS + NIRS (near-infrared spectroscopy).
Market Cap (Nipro): Approx. $4 billion.
Strength: Dual imaging technology and coronary plaque characterization.
About: Canadian innovator in hybrid intravascular imaging.
Products: Novasight Hybrid System (IVUS + OCT).
Market Cap: Private company.
Strength: First-in-class hybrid IVUS-OCT imaging in a single catheter.
About: A subsidiary of Canon Inc., Japan.
Products: Angiography and IVUS solutions (formerly Toshiba Medical).
Market Cap (Canon Inc.): Approx. $30 billion.
Strength: Integration of imaging modalities and AI capabilities.
About: U.S.-based medtech leader, recently spun off from GE.
Products: Developing OCT and vascular imaging platforms.
Market Cap: Around $35 billion.
Strength: Expanding portfolio with investments in cardiovascular imaging.
About: German medtech company with global operations.
Products: Advanced imaging platforms, with partnerships for IVUS/OCT.
Market Cap: Approx. $60 billion.
Strength: AI-enabled diagnostics and hospital integration.
About: U.S.-based AI startup focusing on ultrasound.
Products: AI-guided cardiac ultrasound systems.
Market Cap: Acquired by GE HealthCare in 2023.
Strength: AI innovations for automated intravascular imaging analysis.
About: Leading Chinese manufacturer of minimally invasive surgical devices.
Products: Exploring entry into cardiovascular imaging market.
Market Cap: Approx. $1.2 billion.
Strength: Rapidly expanding product innovation in Asia.
About: Indian medical devices firm with global outreach.
Products: Imaging-enabled interventional cardiology systems.
Market Cap: Private company.
Strength: Strong R&D and growing footprint in emerging markets.
About: One of the world’s largest medical device firms.
Products: Coronary imaging tools, acquisition strategy for tech expansion.
Market Cap: Approx. $100 billion.
Strength: Global leader in CVD treatment with investment in imaging tech.
Request a customized case study tailored to your business needs and gain deeper insights
into healthcare market strategies: sales@towardshealthcare.com
The market is growing due to rising cases of cardiovascular diseases, innovations in imaging technology, and demand for precision-guided interventions using IVUS and OCT.
North America holds the largest market share (~48% in 2024), driven by advanced healthcare infrastructure and high adoption rates.
The OCT segment is expected to register a CAGR of over 8% during 2025–2034 due to its high-resolution imaging capabilities.
AI is being integrated to improve image analysis, automate plaque detection, and guide stent placement, leading to better procedural outcomes.
Yes, companies like Conavi Medical have developed systems that combine IVUS and OCT for comprehensive intravascular imaging in a single procedure.
Invest in Our Premium Strategic Solution: https://www.towardshealthcare.com/price/5894
The global digital health and wellness market is projected to expand from US$ 498.99 billion in 2024 to US$ 3,568.11… Read More
The global radiopharmaceutical market is projected to grow from USD 6.8 billion in 2024 to USD 14.11 billion by 2034,… Read More
The U.S. life science market is on an upward trajectory, poised to generate substantial revenue growth, potentially climbing into the… Read More
The U.S. cell therapy market size is forecast to grow at a CAGR of 21.46%, from USD 8.04 billion in… Read More
The global animal biotechnology market was USD 28.17 billion in 2024, rose to USD 30.97 billion in 2025, and is… Read More
The global ophthalmology devices market was US$ 7.51 billion in 2024, rose to US$ 7.89 billion in 2025, and is… Read More